IRIS Accounts Production v25.2.0.378 SC248051 Board of Directors 1.10.23 30.9.24 30.9.24 Medium entities The principal activity of the company is the provision of care and education for young people. 217 220 true false true true false false true false Auditors Opinion These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC2480512023-09-30SC2480512024-09-30SC2480512023-10-012024-09-30SC2480512022-09-30SC2480512022-10-012023-09-30SC2480512023-09-30SC248051ns15:Scotland2023-10-012024-09-30SC248051ns14:PoundSterling2023-10-012024-09-30SC248051ns10:Director12023-10-012024-09-30SC248051ns10:PrivateLimitedCompanyLtd2023-10-012024-09-30SC248051ns10:MediumEntities2023-10-012024-09-30SC248051ns10:Audited2023-10-012024-09-30SC248051ns10:Medium-sizedCompaniesRegimeForDirectorsReport2023-10-012024-09-30SC248051ns10:Medium-sizedCompaniesRegimeForAccounts2023-10-012024-09-30SC248051ns10:FullAccounts2023-10-012024-09-30SC248051ns10:OrdinaryShareClass12023-10-012024-09-30SC248051ns10:Director22023-10-012024-09-30SC248051ns10:RegisteredOffice2023-10-012024-09-30SC248051ns5:CurrentFinancialInstruments2024-09-30SC248051ns5:CurrentFinancialInstruments2023-09-30SC248051ns5:Non-currentFinancialInstruments2024-09-30SC248051ns5:Non-currentFinancialInstruments2023-09-30SC248051ns5:ShareCapital2024-09-30SC248051ns5:ShareCapital2023-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2024-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2023-09-30SC248051ns5:ShareCapital2022-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2022-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2022-10-012023-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-30SC24805112023-10-012024-09-30SC248051ns5:PlantMachinery2023-10-012024-09-30SC248051ns5:MotorVehicles2023-10-012024-09-30SC248051ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-10-012024-09-30SC248051ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2022-10-012023-09-30SC248051ns5:OwnedAssets2023-10-012024-09-30SC248051ns5:OwnedAssets2022-10-012023-09-30SC248051ns5:LeasedAssets2023-10-012024-09-30SC248051ns5:LeasedAssets2022-10-012023-09-30SC248051ns5:HirePurchaseContracts2023-10-012024-09-30SC248051ns5:HirePurchaseContracts2022-10-012023-09-30SC248051ns5:LandBuildings2023-09-30SC248051ns5:PlantMachinery2023-09-30SC248051ns5:MotorVehicles2023-09-30SC248051ns5:LandBuildings2023-10-012024-09-30SC248051ns5:LandBuildings2024-09-30SC248051ns5:PlantMachinery2024-09-30SC248051ns5:MotorVehicles2024-09-30SC248051ns5:LandBuildings2023-09-30SC248051ns5:PlantMachinery2023-09-30SC248051ns5:MotorVehicles2023-09-30SC248051ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-09-30SC248051ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-10-012024-09-30SC248051ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-09-30SC248051ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2023-09-30SC248051ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-30SC248051ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30SC248051ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-09-30SC248051ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-09-30SC248051ns5:WithinOneYearns5:HirePurchaseContracts2024-09-30SC248051ns5:WithinOneYearns5:HirePurchaseContracts2023-09-30SC248051ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-09-30SC248051ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2023-09-30SC248051ns5:HirePurchaseContracts2024-09-30SC248051ns5:HirePurchaseContracts2023-09-30SC248051ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-09-30SC248051ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2023-09-30SC248051ns5:WithinOneYear2024-09-30SC248051ns5:WithinOneYear2023-09-30SC248051ns5:BetweenOneFiveYears2024-09-30SC248051ns5:BetweenOneFiveYears2023-09-30SC248051ns5:AllPeriods2024-09-30SC248051ns5:AllPeriods2023-09-30SC248051ns10:OrdinaryShareClass12024-09-30SC248051ns5:RetainedEarningsAccumulatedLosses2023-09-30
REGISTERED NUMBER: SC248051 (Scotland)













STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

CURO SALUS LIMITED

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 4

Income Statement 7

Other Comprehensive Income 8

Balance Sheet 9

Statement of Changes in Equity 10

Cash Flow Statement 11

Notes to the Cash Flow Statement 12

Notes to the Financial Statements 14


CURO SALUS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: Mrs J Boucetta
Ms K Hampson



REGISTERED OFFICE: Wardhouse Farm
Forehouse Road
Kilbarchan
RENFREWSHIRE
PA10 2PU



REGISTERED NUMBER: SC248051 (Scotland)



SENIOR STATUTORY AUDITOR: Douglas Paton BSc CA



AUDITORS: Bannerman Johnstone Maclay
Chartered Accountants
and Statutory Auditor
213 St Vincent Street
Glasgow
G2 5QY

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their strategic report for the year ended 30 September 2024.

The principal activity of the company is the provision of care and education for young people.

REVIEW OF BUSINESS
The directors are pleased with the financial results for the year. Investment in staff training and recruitment remained a priority to address sector-wide workforce challenges and maintain high standards of care and education.

The organisation operates within a highly regulated environment overseen by the Care Inspectorate and Education Scotland, requiring compliance with rigorous standards for safeguarding, quality of care, and educational outcomes. The company remains committed to delivering exceptional care and education to vulnerable children, supporting their growth and wellbeing in a safe and supportive environment.

PRINCIPAL RISKS AND UNCERTAINTIES
During the forthcoming year the board consider the principal risks and uncertainties affecting the company to be:

- Regulatory Compliance
- Workforce Challenges
- Government Policy
- Local Authority Funding

Having considered the risks to the organisation, the board are of the opinion that the company has taken positive action and responded to mitigate the impact of these risks and uncertainties.

KEY PERFORMANCE INDICATORS
The directors and senior management of the company regularly monitor the performance of the organisation with reference to key performance indicators (KPIs) such as occupancy, staff turnover, and educational progress metrics were closely monitored to ensure continuous improvement.

ON BEHALF OF THE BOARD:





Ms K Hampson - Director


26 September 2025

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their report with the financial statements of the company for the year ended 30 September 2024.

DIVIDENDS
No dividends will be distributed for the year ended 30 September 2024.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2023 to the date of this report.

Mrs J Boucetta
Ms K Hampson

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that she ought to have taken as a director in order to make herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Bannerman Johnstone Maclay, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





Ms K Hampson - Director


26 September 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
CURO SALUS LIMITED


Qualified opinion
We have audited the financial statements of Curo Salus Limited (the 'company') for the year ended 30 September 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion, except for the possible effects of the matters described in the Basis for Qualified Opinion section the accompanying financial statements give a true and fair view of the financial position of the Company as at 30 September, 2024, and of its financial performance and its cash flows for the year then ended in accordance with Financial Reporting Standard 102.

Basis for qualified opinion
The financial statements do not include certain disclosures in respect of directors' remuneration that are required by Section 412 of the Companies Act 2006. In our judgement,this constitutes a departure from the disclosure requirements of the Act.

The financial statements do not include certain disclosures in respect of related party transactions that are required by Section 33 of FRS 102. In our judgement, the omission of this information constitutes a departure from the requirements of FRS 102.

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
CURO SALUS LIMITED


Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

As referred to in the Basis for Qualified Opinion, there has been an omission of information regarding directors' remuneration required by the Companies Act 2026.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
CURO SALUS LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

- We obtained an understanding of the legal and regulatory frameworks applicable to the company and the sector
in which it operates. We determined that the following laws and regulations were the most significant: the
Companies Act 2006 and UK corporate taxation laws.
- We obtained an understanding of how the company is complying with those legal and regulatory frameworks by
making enquires to the management.
- We assessed the susceptibility of the company's financial statements to material misstatement, including how
fraud might occur. Audit procedures performed by the engagement team included:

- identifying and assessing the design and effectiveness of controls management has in place to prevent and
detect fraud;

- understanding how those charged with governance considered and addressed the potential for override of
controls or other inappropriate influence over the financial reporting process;
- challenging assumptions and judgements made by management in its significant accounting estimates;

- identifying and testing journal entries, in particular any journal entries posted with unusual accounting
combinations; and
- assessing the extent of compliance with relevant laws and regulations.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Douglas Paton BSc CA (Senior Statutory Auditor)
for and on behalf of Bannerman Johnstone Maclay
Chartered Accountants
and Statutory Auditor
213 St Vincent Street
Glasgow
G2 5QY

26 September 2025

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

INCOME STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2024 2023
Notes £    £   

TURNOVER 12,816,733 12,567,299

Cost of sales 10,018,157 9,898,624
GROSS PROFIT 2,798,576 2,668,675

Administrative expenses 1,755,499 1,591,393
OPERATING PROFIT 4 1,043,077 1,077,282

Interest receivable and similar income 579 -
1,043,656 1,077,282
Gain/loss on revaluation of tangible assets (2,745,592 ) -
(1,701,936 ) 1,077,282

Interest payable and similar expenses 5 24,631 42,927
(LOSS)/PROFIT BEFORE TAXATION (1,726,567 ) 1,034,355

Tax on (loss)/profit 6 210,730 263,358
(LOSS)/PROFIT FOR THE FINANCIAL
YEAR

(1,937,297

)

770,997

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2024 2023
Notes £    £   

(LOSS)/PROFIT FOR THE YEAR (1,937,297 ) 770,997


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

(1,937,297

)

770,997

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

BALANCE SHEET
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 7 3,665,277 6,433,652

CURRENT ASSETS
Debtors 8 1,166,950 1,251,216
Cash at bank 1,370,988 933,223
2,537,938 2,184,439
CREDITORS
Amounts falling due within one year 9 2,375,159 2,758,385
NET CURRENT ASSETS/(LIABILITIES) 162,779 (573,946 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,828,056

5,859,706

CREDITORS
Amounts falling due after more than one
year

10

55,281

149,634
NET ASSETS 3,772,775 5,710,072

CAPITAL AND RESERVES
Called up share capital 13 2 2
Retained earnings 14 3,772,773 5,710,070
SHAREHOLDERS' FUNDS 3,772,775 5,710,072

The financial statements were approved by the Board of Directors and authorised for issue on 26 September 2025 and were signed on its behalf by:





Ms K Hampson - Director


CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 October 2022 2 4,939,073 4,939,075

Changes in equity
Total comprehensive income - 770,997 770,997
Balance at 30 September 2023 2 5,710,070 5,710,072

Changes in equity
Total comprehensive income - (1,937,297 ) (1,937,297 )
Balance at 30 September 2024 2 3,772,773 3,772,775

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2024 2023
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,126,158 953,849
Interest paid (16,124 ) (28,452 )
Interest element of hire purchase payments
paid

(8,507

)

(14,475

)
Tax paid (263,316 ) (115,753 )
Net cash from operating activities 838,211 795,169

Cash flows from investing activities
Purchase of tangible fixed assets (58,458 ) (45,343 )
Sale of tangible fixed assets - 64,582
Interest received 579 -
Net cash from investing activities (57,879 ) 19,239

Cash flows from financing activities
Loan repayments in year (273,932 ) (258,786 )
Capital repayments in year (68,635 ) (124,634 )
Amount introduced by directors - 19,410
Net cash from financing activities (342,567 ) (364,010 )

Increase in cash and cash equivalents 437,765 450,398
Cash and cash equivalents at beginning of
year

2

933,223

482,825

Cash and cash equivalents at end of year 2 1,370,988 933,223

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. RECONCILIATION OF (LOSS)/PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2024 2023
£    £   
(Loss)/profit before taxation (1,726,567 ) 1,034,355
Depreciation charges 142,615 195,519
Profit on disposal of fixed assets - (15,205 )
Loss on revaluation of fixed assets 2,745,592 -
Finance costs 24,631 42,927
Finance income (579 ) -
1,185,692 1,257,596
Decrease/(increase) in trade and other debtors 129,051 (117,854 )
Decrease in trade and other creditors (188,585 ) (185,893 )
Cash generated from operations 1,126,158 953,849

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 30 September 2024
30.9.24 1.10.23
£    £   
Cash and cash equivalents 1,370,988 933,223
Year ended 30 September 2023
30.9.23 1.10.22
£    £   
Cash and cash equivalents 933,223 482,825


CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024


3. ANALYSIS OF CHANGES IN NET FUNDS

Other
non-cash
At 1.10.23 Cash flow changes At 30.9.24
£    £    £    £   
Net cash
Cash at bank 933,223 437,765 1,370,988
933,223 437,765 1,370,988
Debt
Finance leases (115,500 ) 68,635 - (108,239 )
Debts falling due
within 1 year (261,752 ) 190,046 - (71,706 )
Debts falling due
after 1 year (83,886 ) 83,886 - -
(461,138 ) 342,567 - (179,945 )
Total 472,085 780,332 - 1,191,043

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

Curo Salus Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Critical accounting judgements and key sources of estimation uncertainty
The preparation of financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities as at the balance sheet date and the amounts reported during the year for revenue and costs. However the nature of estimation means that actual outcomes could differ from those estimates. Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Useful economic lives of tangible assets
The annual depreciation charge for tangible assets is sensitive to changes in the useful economic lives and residual values of the assets. Useful lives and residual values are reassessed annually. They are assessed where necessary to reflect current estimates based on economic utilisation and physical condition.

Impairment of trade and other debtors
The Company regularly reviews the recoverability of trade and other debtors. A provision for impairment is made where the Company believes that it will not be able to collect amounts due according to the original terms of trade. Provisions for impairment are estimates of future events and are therefore uncertain.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery - 33% on cost and 10% on cost
Motor vehicles - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

2024 2023
£ £
Wages and salaries 8,246,165 8,234,307
Social security costs 871,829 898,059
Other pension costs 341,473 271,096
9,459,467 9,403,462

The average number of employees during the year was as follows:


2024 2023

Employees 215 218
Directors 2 2
217 220


CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


4. OPERATING (LOSS)/PROFIT

The operating loss (2023 - operating profit) is stated after charging/(crediting):

2024 2023
£    £   
Hire of plant and machinery 72,629 68,359
Depreciation - owned assets 79,319 138,006
Depreciation - assets on hire purchase contracts 63,296 57,513
Profit on disposal of fixed assets - (15,205 )
Auditors' remuneration 16,200 -

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
£    £   
Bank interest 16,124 28,452
Hire purchase 8,507 14,475
24,631 42,927

6. TAXATION

Analysis of the tax charge
The tax charge on the loss for the year was as follows:
2024 2023
£    £   
Current tax:
UK corporation tax 255,515 263,358

Deferred tax (44,785 ) -
Tax on (loss)/profit 210,730 263,358

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


7. TANGIBLE FIXED ASSETS
Freehold Plant and Motor
property machinery vehicles Totals
£    £    £    £   
COST OR VALUATION
At 1 October 2023 6,195,592 1,076,875 906,750 8,179,217
Additions - - 119,832 119,832
Revaluations (2,745,592 ) - - (2,745,592 )
At 30 September 2024 3,450,000 1,076,875 1,026,582 5,553,457
DEPRECIATION
At 1 October 2023 - 1,017,472 728,093 1,745,565
Charge for year - 34,753 107,862 142,615
At 30 September 2024 - 1,052,225 835,955 1,888,180
NET BOOK VALUE
At 30 September 2024 3,450,000 24,650 190,627 3,665,277
At 30 September 2023 6,195,592 59,403 178,657 6,433,652

All properties were valued in 2024 by Shepherd Commercial, Chartered Surveyors. The valuations were prepared in line with the RICS Red Book guidance and in accordance with the RICS Global Standards incorporating the IVSC International Valuation Standards . This valuation has been incorporated in the accounts.

Cost or valuation at 30 September 2024 is represented by:

Freehold Plant and Motor
property machinery vehicles Totals
£    £    £    £   
Valuation in 2024 (2,745,592 ) - - (2,745,592 )
Cost 6,195,592 1,076,875 1,026,582 8,299,049
3,450,000 1,076,875 1,026,582 5,553,457

If land and buildings had not been revalued they would have been included at the following historical cost:

2024 2023
£    £   
Cost 6,195,592 6,195,592

All properties were valued on an open market basis on 13 August 2023 by J & E Shepherd Surveyors .

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


7. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST OR VALUATION
At 1 October 2023 230,054
Additions 61,374
At 30 September 2024 291,428
DEPRECIATION
At 1 October 2023 170,119
Charge for year 63,296
At 30 September 2024 233,415
NET BOOK VALUE
At 30 September 2024 58,013
At 30 September 2023 59,935

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 1,122,165 1,251,216
Deferred tax asset 44,785 -
1,166,950 1,251,216

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts (see note 11) 71,706 261,752
Hire purchase contracts (see note 12) 52,958 49,752
Trade creditors 58,304 36,243
Tax 255,557 263,358
Social security and other taxes 243,980 215,435
Other creditors 29,786 -
Directors' loan accounts 3,270 3,270
Accruals and deferred income 1,659,598 1,928,575
2,375,159 2,758,385

10. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans (see note 11) - 83,886
Hire purchase contracts (see note 12) 55,281 65,748
55,281 149,634

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


11. LOANS

An analysis of the maturity of loans is given below:

2024 2023
£    £   
Amounts falling due within one year or on demand:
Bank loans 71,706 261,752

Amounts falling due between one and two years:
Bank loans - 83,886

12. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase
contracts
2024 2023
£    £   
Gross obligations repayable:
Within one year 58,599 58,259
Between one and five years 60,413 76,520
119,012 134,779

Finance charges repayable:
Within one year 5,641 8,507
Between one and five years 5,132 10,772
10,773 19,279

Net obligations repayable:
Within one year 52,958 49,752
Between one and five years 55,281 65,748
108,239 115,500

Non-cancellable
operating leases
2024 2023
£    £   
Within one year 80,727 71,845
Between one and five years 311,566 -
392,293 71,845

CURO SALUS LIMITED (REGISTERED NUMBER: SC248051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


13. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
2 Ordinary £1 2 2

14. RESERVES
Retained
earnings
£   

At 1 October 2023 5,710,070
Deficit for the year (1,937,297 )
At 30 September 2024 3,772,773